Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.47 |
| ▸ | TDO2 | P48775 | 4/20 | 0.47 |
| ▸ | SCN1A | P35498 | 3/20 | 0.45 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.45 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23296602 | 0.97 | IDO1 (0.46) | IDO1TDO2SCN1ASCN2ASCN3A | |
| SCHEMBL13697238 | 0.88 | MLKL (0.51) | IDO1TDO2LMNATSHRSMN1; SMN2 | |
| SCHEMBL9097250 | 0.88 | SMN1; SMN2 (0.50) | IDO1TDO2CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL6751142 | 0.88 | IDO1 (0.41) | IDO1TDO2SCN1ASCN2ASCN3A | |
| SCHEMBL13772542 | 0.86 | IDO1 (0.64) | IDO1TDO2LMNATSHRCYP1A2 | |
| SCHEMBL17599983 | 0.86 | ACP3 (0.56) | TSHRNPSR1MAPK1CA4 | |
| SCHEMBL15960120 | 0.86 | IDO1 (0.39) | IDO1TDO2SCN1ASCN2ASCN3A | |
| SCHEMBL23296776 | 0.86 | IDO1 (0.39) | IDO1TDO2SCN1ASCN2ASCN3A | |
| SCHEMBL7586879 | 0.86 | IDO1 (0.39) | IDO1TDO2SCN1ASCN2ASCN3A | |
| SCHEMBL1773224 | 0.86 | SLC6A4 (0.54) | IDO1TDO2LMNACHRM2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210130408-A1 | COMPOUND AND METHOD FOR PRODUCING THE SAME | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2021-05-06 | — | — | US | claimed |
| EP-2621462-B1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | PROCTER & GAMBLE (US) | 2020-02-12 | — | — | EP | claimed |
| CN-104844426-A | Bis anisole derivative synthesis method | UNIV CHONGQING | 2015-08-19 | — | — | CN | claimed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | claimed |
| WO-2012091154-A1 | METHOD OF PRODUCING A HYDROLYZABLE SILICON-CONTAINING COMPOUND | WASEDA UNIVERSITY (JP) | 2012-07-05 | — | — | WO | claimed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | claimed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | claimed |
| US-4617401-A | ANTISPASMODIC AGENTS, VASODILATORS | SUNTORY LTD. (JP) | 1986-10-14 | — | — | US | claimed |
| EP-0039903-B1 | 8-SUBSTITUTED PYRROLIZIDINES AND QUATERNARY AMMONIUM SALTS THEREOF | SUNTORY KABUSHIKI KAISHA (JP) | 1986-04-09 | — | — | EP | claimed |
| US-4315986-A | DIPHENYMETHANE NUCLEATING AGENTS | EASTMAN KODAK COMPANY (US) | 1982-02-16 | — | — | US | claimed |
| EP-0039903-A2 | 8-Substituted pyrrolizidines and quaternary ammonium salts thereof | SUNTORY KABUSHIKI KAISHA (JP) | 1981-11-18 | — | — | EP | claimed |
| US-20250215582-A1 | ELECTROCHEMICAL REACTOR AND PROCESSES USING THE ELECTROCHEMICAL REACTOR | Karl-Franzens-Universität Graz (AT) | 2025-07-03 | — | — | US | disclosed |
| EP-3383502-B1 | ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOF | COLGATE PALMOLIVE CO (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-4499895-A2 | ELECTROCHEMICAL REACTOR AND PROCESSES USING THE ELECTROCHEMICAL REACTOR | Karl-Franzens-Universität Graz (AT) | 2025-02-05 | — | — | EP | disclosed |
| US-20240399360-A1 | DEVICES AND METHODS FOR CREATING TRANSCELLULAR PORES | GEORGIA TECH RES INST (US) | 2024-12-05 | — | — | US | disclosed |
| US-4049823-A | Phenylbutanol derivatives and compositions containing them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-20 | — | — | US | disclosed |
| US-4001279-A | CARRY INSOLUBLE REAGENT SUBSTANCES INTO SOLUTION IN NON-HYDROXYLIC MEDIA; CROWN COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1977-01-04 | — | — | US | disclosed |
| US-3965116-A | COMPLEXING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1976-06-22 | — | — | US | disclosed |
| US-3959475-A | ANTIDEPRESSANT, TRANQUILIZER, ANALGESIC | AMERICAN HOECHST CORPORATION (US) | 1976-05-25 | — | — | US | disclosed |
| US-3957828-A | 3-Aminoalkyl-1,3-dihydro-3-phenylspiro[isobenzofurans] | AMERICAN HOECHST CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130408-A1 | COMPOUND AND METHOD FOR PRODUCING THE SAME | DAO, DNPEP, DCXR | IDO1 1339/4885TDO2 520/4885SCN1A 4849/4885 |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | IDO1 1565/4885TDO2 827/4885SCN1A 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.